UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:RPL41-CD74 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: RPL41-CD74 | FusionPDB ID: 76856 | FusionGDB2.0 ID: 76856 | Hgene | Tgene | Gene symbol | RPL41 | CD74 | Gene ID | 6171 | 972 |
Gene name | ribosomal protein L41 | CD74 molecule | |
Synonyms | L41 | DHLAG|HLADG|II|Ia-GAMMA|p33 | |
Cytomap | 12q13.2 | 5q33.1 | |
Type of gene | protein-coding | protein-coding | |
Description | 60S ribosomal protein L41HG12 proteinhomologue of yeast ribosomal protein YL41large ribosomal subunit protein eL41 | HLA class II histocompatibility antigen gamma chainCD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)CD74 molecule, major histocompatibility complex, class II invariant chainHLA-DR antigens-associated | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P04233 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000552314, ENST00000501597, ENST00000546591, | ENST00000009530, ENST00000353334, ENST00000377795, ENST00000524315, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 11 X 14 X 6=924 | 31 X 31 X 11=10571 |
# samples | 16 | 39 | |
** MAII score | log2(16/924*10)=-2.5298209465287 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(39/10571*10)=-4.76049392566144 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: RPL41 [Title/Abstract] AND CD74 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RPL41(56510577)-CD74(149792311), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | RPL41-CD74 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RPL41-CD74 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RPL41 | GO:0002181 | cytoplasmic translation | 25957688 |
Tgene | CD74 | GO:0001516 | prostaglandin biosynthetic process | 12782713 |
Tgene | CD74 | GO:0001934 | positive regulation of protein phosphorylation | 24942581 |
Tgene | CD74 | GO:0002792 | negative regulation of peptide secretion | 19849849 |
Tgene | CD74 | GO:0033674 | positive regulation of kinase activity | 24942581 |
Tgene | CD74 | GO:0043066 | negative regulation of apoptotic process | 12782713 |
Tgene | CD74 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 24942581 |
Tgene | CD74 | GO:0043410 | positive regulation of MAPK cascade | 24942581 |
Tgene | CD74 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 17045821 |
Tgene | CD74 | GO:0045657 | positive regulation of monocyte differentiation | 24942581 |
Tgene | CD74 | GO:0045893 | positive regulation of transcription, DNA-templated | 24942581 |
Tgene | CD74 | GO:0046598 | positive regulation of viral entry into host cell | 24942581 |
Tgene | CD74 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 17045821 |
Tgene | CD74 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 17045821|24942581 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LAML | TCGA-AB-2979_631TVAAXX_4 | RPL41 | chr12 | 56510577 | + | CD74 | chr5 | 149792311 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000546591 | RPL41 | chr12 | 56510577 | + | ENST00000377795 | CD74 | chr5 | 149792311 | - | 1331 | 214 | 1292 | 801 | 163 |
ENST00000546591 | RPL41 | chr12 | 56510577 | + | ENST00000353334 | CD74 | chr5 | 149792311 | - | 1482 | 214 | 1443 | 760 | 227 |
ENST00000546591 | RPL41 | chr12 | 56510577 | + | ENST00000524315 | CD74 | chr5 | 149792311 | - | 798 | 214 | 782 | 0 | 261 |
ENST00000546591 | RPL41 | chr12 | 56510577 | + | ENST00000009530 | CD74 | chr5 | 149792311 | - | 1195 | 214 | 195 | 1106 | 303 |
ENST00000501597 | RPL41 | chr12 | 56510577 | + | ENST00000377795 | CD74 | chr5 | 149792311 | - | 1212 | 95 | 1173 | 682 | 163 |
ENST00000501597 | RPL41 | chr12 | 56510577 | + | ENST00000353334 | CD74 | chr5 | 149792311 | - | 1363 | 95 | 1324 | 641 | 227 |
ENST00000501597 | RPL41 | chr12 | 56510577 | + | ENST00000524315 | CD74 | chr5 | 149792311 | - | 679 | 95 | 663 | 52 | 203 |
ENST00000501597 | RPL41 | chr12 | 56510577 | + | ENST00000009530 | CD74 | chr5 | 149792311 | - | 1076 | 95 | 76 | 987 | 303 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >76856_76856_1_RPL41-CD74_RPL41_chr12_56510577_ENST00000501597_CD74_chr5_149792311_ENST00000009530_length(amino acids)=303AA_BP=7 MRHESQEMHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTV TSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTM ETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNT -------------------------------------------------------------- >76856_76856_2_RPL41-CD74_RPL41_chr12_56510577_ENST00000501597_CD74_chr5_149792311_ENST00000353334_length(amino acids)=227AA_BP=1 MLIVGDKVALVIHDWLLIFPTAPASPPVQLGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALAPGA GLPWAAPASAAGWPCASCSQAWELEQVHHMVLCHVAILGGILHGLPVYGLHGVLKVSQVLREAPLQWRVHLQGVSILSVERQWAFAPRSA -------------------------------------------------------------- >76856_76856_3_RPL41-CD74_RPL41_chr12_56510577_ENST00000501597_CD74_chr5_149792311_ENST00000377795_length(amino acids)=163AA_BP=1 MLIVGDKVALVIHDWLLIFPTAPASPPVQLGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALAPGA -------------------------------------------------------------- >76856_76856_4_RPL41-CD74_RPL41_chr12_56510577_ENST00000501597_CD74_chr5_149792311_ENST00000524315_length(amino acids)=203AA_BP=1 MGVGLSLLPVPSHLVHEPRSWSLVLEAAVMSGTGICLAFGHFLEQVHHMVLCHVAILGGILHGPLGQGSHGQRLHQQRGGHAHLAHRLGR LGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALALRGPRAPAQHGQLLIVGDKVALVIHDWLLIFP -------------------------------------------------------------- >76856_76856_5_RPL41-CD74_RPL41_chr12_56510577_ENST00000546591_CD74_chr5_149792311_ENST00000009530_length(amino acids)=303AA_BP=7 MRHESQEMHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTV TSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTM ETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNT -------------------------------------------------------------- >76856_76856_6_RPL41-CD74_RPL41_chr12_56510577_ENST00000546591_CD74_chr5_149792311_ENST00000353334_length(amino acids)=227AA_BP=1 MLIVGDKVALVIHDWLLIFPTAPASPPVQLGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALAPGA GLPWAAPASAAGWPCASCSQAWELEQVHHMVLCHVAILGGILHGLPVYGLHGVLKVSQVLREAPLQWRVHLQGVSILSVERQWAFAPRSA -------------------------------------------------------------- >76856_76856_7_RPL41-CD74_RPL41_chr12_56510577_ENST00000546591_CD74_chr5_149792311_ENST00000377795_length(amino acids)=163AA_BP=1 MLIVGDKVALVIHDWLLIFPTAPASPPVQLGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALAPGA -------------------------------------------------------------- >76856_76856_8_RPL41-CD74_RPL41_chr12_56510577_ENST00000546591_CD74_chr5_149792311_ENST00000524315_length(amino acids)=261AA_BP=1 MGVGLSLLPVPSHLVHEPRSWSLVLEAAVMSGTGICLAFGHFLEQVHHMVLCHVAILGGILHGPLGQGSHGQRLHQQRGGHAHLAHRLGR LGKLHAQVLQLQVLGGDCQFVQPALLLVQEVGGGGLASEEQSHQDGKACVQGSAAALALRGPRAPAQHGQLLIVGDKVALVIHDWLLIFP -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:56510577/chr5:149792311) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | CD74 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha/beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal/lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. Serves as cell surface receptor for the cytokine MIF.; FUNCTION: [Class-II-associated invariant chain peptide]: Binds to the peptide-binding site of MHC class II alpha/beta heterodimers forming an alpha-beta-CLIP complex, thereby preventing the loading of antigenic peptides to the MHC class II complex until its release by HLA-DM in the endosome. {ECO:0000269|PubMed:1448172}.; FUNCTION: [Isoform p41]: Stabilizes the conformation of mature CTSL by binding to its active site and serving as a chaperone to help maintain a pool of mature enzyme in endocytic compartments and extracellular space of antigen-presenting cells (APCs). Has antiviral activity by stymieing the endosomal entry of Ebola virus and coronaviruses, including SARS-CoV-2 (PubMed:32855215). Disrupts cathepsin-mediated Ebola virus glycoprotein processing, which prevents viral fusion and entry. This antiviral activity is specific to p41 isoform (PubMed:32855215). {ECO:0000250|UniProtKB:P04441, ECO:0000269|PubMed:32855215}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000009530 | -1 | 9 | 210_271 | 41.666666666666664 | 297.0 | Domain | Thyroglobulin type-1 | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000353334 | 0 | 8 | 210_271 | 0 | 233.0 | Domain | Thyroglobulin type-1 | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000377795 | 0 | 6 | 210_271 | 0 | 280.6666666666667 | Domain | Thyroglobulin type-1 | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000009530 | -1 | 9 | 73_296 | 41.666666666666664 | 297.0 | Topological domain | Extracellular | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000353334 | 0 | 8 | 1_46 | 0 | 233.0 | Topological domain | Cytoplasmic | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000353334 | 0 | 8 | 73_296 | 0 | 233.0 | Topological domain | Extracellular | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000377795 | 0 | 6 | 1_46 | 0 | 280.6666666666667 | Topological domain | Cytoplasmic | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000377795 | 0 | 6 | 73_296 | 0 | 280.6666666666667 | Topological domain | Extracellular | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000009530 | -1 | 9 | 47_72 | 41.666666666666664 | 297.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000353334 | 0 | 8 | 47_72 | 0 | 233.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein | |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000377795 | 0 | 6 | 47_72 | 0 | 280.6666666666667 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CD74 | chr12:56510577 | chr5:149792311 | ENST00000009530 | -1 | 9 | 1_46 | 41.666666666666664 | 297.0 | Topological domain | Cytoplasmic |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
CD74 | MIF, CD74, APP, HADHA, LAMTOR5, MAP3K1, TM4SF20, COPG1, COPG2, HLA-DPB1, HLA-DQA1, nef, CD44, AKAP8, ANKRD28, AP3D1, ARCN1, ASCC1, ASCC3, ASNS, CANX, CHAF1B, COPA, COPB1, COPB2, COPE, DDX60, DGKE, DNAJB11, DNAJB12, EIF1, EIF2B3, EIF2B4, EIF2B5, EIF2S1, EIF2S3, EIF3A, EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J, EIF3K, EIF3L, EIF3M, EIF4A1, EIF4G1, EIF4G2, FKBP8, GANAB, GEMIN4, GRAMD1A, GTF2I, GTF3C1, HADHB, HMOX2, HUWE1, IPO13, IQGAP2, KPNB1, KRT1, LTN1, MAP1B, MTOR, NCAPD2, NCAPD3, NCAPH, OSBPL8, PCNA, PDAP1, PDCD4, PGRMC1, PGRMC2, PHB, POLR2E, POLR3A, POLR3B, PPP6R1, PPP6R3, PRRC2A, PRRC2B, PRRC2C, PSMC2, PSMD3, PSMD6, RCN1, RHOT2, RWDD1, SGPL1, SNRPE, SRP9, TBRG4, TJP2, TPP2, TUBA1A, TUBA1C, UBE3C, UBR4, UBR5, VDAC1, VWA8, YWHAB, YWHAE, YWHAQ, YWHAZ, IFITM3, FDFT1, POMGNT1, BET1, TMEM97, UPK2, TEX11, SERP1, SLC35B1, SEC22A, PLP1, TMEM254, C14orf1, TMEM243, TMEM60, FXYD6, CMTM7, CLDN19, LPAR3, CLEC7A, EDDM3B, C14orf180, PTCH1, TMEM120B, RTP2, PPAPDC1A, PGA4, SMIM1, CUL7, CCR1, ROPN1L, HLA-DRB3, HLA-DRB1, HLA-DRA, |
![]() |
Gene | STRING network |
RPL41 | |
CD74 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to RPL41-CD74 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RPL41-CD74 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CD74 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | CD74 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | CD74 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CD74 | C0162557 | Liver Failure, Acute | 1 | CTD_human |
Tgene | CD74 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | CD74 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | CD74 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | CD74 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |